Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Peringkat dalam Saham #36445
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Harga Saham
$1.73
Terakhir disinkronkan: 2025-06-17
Kapitalisasi Pasar
$2.55M
Perubahan (1 hari)
-0.29%
Perubahan (1 tahun)
-79.71%
Negara
US
Perdagangan Eiger BioPharmaceuticals, Inc. (EIGR)

Kategori

Healthcare
Jumlah saham beredar untuk Eiger BioPharmaceuticals, Inc. (EIGR)
Jumlah saham beredar per December 2023: 1.48M
Menurut laporan keuangan terbaru dan harga saham Eiger BioPharmaceuticals, Inc., jumlah saham beredar saat ini adalah 1.48M. Pada akhir December 2022, perusahaan memiliki 1.39M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Eiger BioPharmaceuticals, Inc. (EIGR) dari 2016 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 1.48M 0.22%
2023 1.48M 6.39%
2022 1.39M 22.64%
2021 1.13M 20.61%
2020 938.11K 23.51%
2019 759.52K 66.18%
2018 457.03K 57.09%
2017 290.93K 45.30%
2016 200.23K 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 17,061.24%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 26,665.85%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 32,269.92%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 4,103.15%
NL